Procalcitonin blood test for predicting infection outcomes
Part of Infections clinical trials.
This study looks at whether a blood test called procalcitonin can help predict how well patients with acute infections will do while in the hospital. If you're currently hospitalized for an infection, your test results and medical records may be reviewed to help improve care for future patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are hospitalized in an internal medicine or geriatric ward.
- You have been diagnosed with an acute infection.
- You had a procalcitonin blood test during this hospitalization.
- You do not have conditions that could falsely raise procalcitonin levels, like major surgery, trauma, or certain cancers.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using a blood test called procalcitonin to decide when to start antibiotics in critically ill patients with a new infection. The goal is to reduce unnecessary antibiotic use while still effectively treating infections.
This study looks at simple blood tests (like levels of certain white blood cells and a protein called procalcitonin) to see if they can predict how well people with sepsis will do in the intensive care unit. It may help doctors understand your infection better.
This study looks at whether a simple blood test can help doctors find out if ICU patients with infections are likely to develop sepsis within the next 48 hours. If you join, the researchers will measure a protein in your blood and follow you to see if you get sepsis.
This study compares two ways of using antibiotics for hospitalized adults with bacterial lower respiratory infections. One group gets antibiotics as usual, while the other group uses a blood test called procalcitonin to guide when to start or stop antibiotics, which may help reduce unnecessary antibiotic use.
This study tests whether a blood test called procalcitonin can help doctors stop intravenous antibiotics earlier in young hospitalized children when an infection seems likely. The goal is to reduce unnecessary antibiotic exposure without missing serious infections.
This trial tests whether using a blood test called procalcitonin (PCT) can help doctors decide when to use antibiotics for critically ill patients in the intensive care unit (ICU). It may help reduce unnecessary antibiotics and improve care.
Hear when a new Procalcitonin trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.